Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Uricosuric effects of niridazole

M Weintraub, T E Nash, E Ottesen

    Clinical Pharmacology and Therapeutics
    |November 1, 1977
    PubMed
    Summary

    Niridazole, an antischistosomal drug, significantly lowered serum uric acid (SUA) levels by 44% in patients with schistosomiasis. This indicates Niridazole possesses uricosuric effects, increasing uric acid excretion.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease.

    Acta neuropathologica communications·2019
    Same author

    Non-fermentative Gram-negative rods bacteremia in children with cancer: a 14-year single-center experience.

    Infection·2017
    Same author

    Revised diagnostic criteria for neurocysticercosis.

    Journal of the neurological sciences·2016
    Same author

    Revised set of diagnostic criteria for neurocysticercosis (in reply to Garg and Malhotra).

    Journal of the neurological sciences·2016
    Same author

    The use of whole exome sequencing for the diagnosis of autosomal recessive malignant infantile osteopetrosis.

    Clinical genetics·2016
    Same author

    Inflammation: a possible mechanism for a causative role of hyperuricemia/gout in cardiovascular disease.

    Current medical research and opinion·2015

    Area of Science:

    • Pharmacology
    • Nephrology
    • Tropical Medicine

    Background:

    • Schistosomiasis is a parasitic disease affecting millions globally.
    • Management of schistosomiasis often involves antiparasitic drugs with potential systemic effects.
    • Serum uric acid (SUA) regulation is crucial for metabolic health.

    Purpose of the Study:

    • To investigate the effect of Niridazole on serum uric acid (SUA) levels.
    • To determine if Niridazole exhibits uricosuric properties.
    • To assess changes in urinary uric acid excretion during Niridazole treatment.

    Main Methods:

    • A study involving 11 patients with schistosomiasis treated with Niridazole.
    • Measurement of serum uric acid (SUA) concentrations at baseline and during treatment.
    • Analysis of urinary uric acid/creatinine ratios and fractional clearance of uric acid.

    Main Results:

    • Niridazole treatment led to a 44% decrease in SUA levels (from 6.3 to 3.5 mg/100 ml).
    • A significant increase in the urinary uric acid/creatinine ratio was observed on day 3.
    • Fractional clearance of uric acid significantly increased, indicating a uricosuric effect.

    Conclusions:

    • Niridazole demonstrates a significant uricosuric effect in patients with schistosomiasis.
    • The drug effectively lowers serum uric acid (SUA) concentrations.
    • Niridazole's uricosuric properties warrant further investigation in related metabolic contexts.

    Related Experiment Videos